These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9801976)

  • 21. Cost-benefit and efficacy of aprotinin compared with epsilon-aminocaproic acid in patients having repeated cardiac operations: a randomized, blinded clinical trial.
    Bennett-Guerrero E; Sorohan JG; Gurevich ML; Kazanjian PE; Levy RR; Barberá AV; White WD; Slaughter TF; Sladen RN; Smith PK; Newman MF
    Anesthesiology; 1997 Dec; 87(6):1373-80. PubMed ID: 9416723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aprotinin and deep hypothermic circulatory arrest: there are no benefits even when appropriate amounts of heparin are given.
    Parolari A; Antona C; Alamanni F; Spirito R; Naliato M; Gerometta P; Arena V; Biglioli P
    Eur J Cardiothorac Surg; 1997 Jan; 11(1):149-56. PubMed ID: 9030804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemostatic effects of aprotinin, tranexamic acid and epsilon-aminocaproic acid in primary cardiac surgery.
    Casati V; Guzzon D; Oppizzi M; Cossolini M; Torri G; Calori G; Alfieri O
    Ann Thorac Surg; 1999 Dec; 68(6):2252-6; discussion 2256-7. PubMed ID: 10617012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of coagulation protection with combination of epsilon aminocaproic acid and plasma saver in open-heart surgery.
    Liu YC; Tsai TP
    Acta Anaesthesiol Sin; 1998 Sep; 36(3):149-54. PubMed ID: 9874863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is use of aprotinin safe with deep hypothermic circulatory arrest in aortic surgery? Investigations on blood coagulation.
    Okita Y; Takamoto S; Ando M; Morota T; Yamaki F; Kawashima Y
    Circulation; 1996 Nov; 94(9 Suppl):II177-81. PubMed ID: 8901742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tranexamic acid reduces bleeding after cardiopulmonary bypass when compared to epsilon aminocaproic acid and placebo.
    Pinosky ML; Kennedy DJ; Fishman RL; Reeves ST; Alpert CC; Ecklund J; Kribbs S; Spinale FG; Kratz JM; Crawford R; Gravlee GP; Dorman BH
    J Card Surg; 1997; 12(5):330-8. PubMed ID: 9635271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the effect of aprotinin and ε-aminocaproic acid on renal function in children undergoing cardiac surgery.
    Leyvi G; Nelson O; Yedlin A; Pasamba M; Belamarich PF; Nair S; Cohen HW
    J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):402-6. PubMed ID: 21419653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Switch from aprotinin to ε-aminocaproic acid: impact on blood loss, transfusion, and clinical outcome in neonates undergoing cardiac surgery.
    Martin K; Gertler R; Liermann H; Mayr NP; MacGuill M; Schreiber C; Vogt M; Tassani P; Wiesner G
    Br J Anaesth; 2011 Dec; 107(6):934-9. PubMed ID: 21857014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing ε-Aminocaproic Acid and Tranexamic Acid in Reducing Postoperative Transfusions in Total Knee Arthroplasty.
    Churchill JL; Puca KE; Meyer E; Carleton M; Anderson MJ
    J Knee Surg; 2017 Jun; 30(5):460-466. PubMed ID: 27699724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of epsilon aminocaproic acid and low-dose aprotinin in cardiopulmonary bypass: efficiency, safety and cost.
    Ray MJ; O'Brien MF
    Ann Thorac Surg; 2001 Mar; 71(3):838-43. PubMed ID: 11269462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Operations on the thoracic aorta and hypothermic circulatory arrest: is aprotinin safe?
    Ehrlich M; Grabenwöger M; Cartes-Zumelzu F; Luckner D; Kovarik J; Laufer G; Kocher A; Konetschny R; Wolner E; Havel M
    J Thorac Cardiovasc Surg; 1998 Jan; 115(1):220-5. PubMed ID: 9451066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of antifibrinolytic agents in spinal surgery: a network meta-analysis.
    Yuan L; Zeng Y; Chen ZQ; Zhang XL; Mai S; Song P; Tao LY
    Chin Med J (Engl); 2019 Mar; 132(5):577-588. PubMed ID: 30807356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-administration of aprotinin and epsilon-aminocaproic acid during cardiopulmonary bypass in a swine model.
    Vang SN; Stammers AH; Mejak BL; Rauch ED; Viessman TW; Bruda NL; Yang T
    J Extra Corpor Technol; 2000 Dec; 32(4):196-206. PubMed ID: 11194056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of effects of aprotinin and tranexamic acid on blood loss in heart surgery].
    Corbeau JJ; Monrigal JP; Jacob JP; Cottineau C; Moreau X; Bukowski JG; Subayi JB; Delhumeau A
    Ann Fr Anesth Reanim; 1995; 14(2):154-61. PubMed ID: 7486272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical application of inhibitors of fibrinolysis.
    Verstraete M
    Drugs; 1985 Mar; 29(3):236-61. PubMed ID: 2580684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tranexamic acid: a review of its use in surgery and other indications.
    Dunn CJ; Goa KL
    Drugs; 1999 Jun; 57(6):1005-32. PubMed ID: 10400410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aprotinin use with hypothermic circulatory arrest for aortic valve and thoracic aortic surgery: renal function and early survival.
    Regragui IA; Bryan AJ; Izzat MB; Wisheart JD; Hutter JA; Angelini GD
    J Heart Valve Dis; 1995 Nov; 4(6):674-7. PubMed ID: 8611985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aminocaproic Acid (amicar) as an alternative to aprotinin (trasylol) in liver transplantation.
    Mangus RS; Kinsella SB; Fridell JA; Kubal CA; Lahsaei P; Mark LO; Tector AJ
    Transplant Proc; 2014 Jun; 46(5):1393-9. PubMed ID: 24935303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of aprotinin and tranexamic acid on fibrinolysis and thrombin generation during cardiopulmonary bypass].
    Risch A; Dorscheid E; Stein G; Seyfert UT; Grundmann U
    Anaesthesist; 2000 Apr; 49(4):279-85. PubMed ID: 10840537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of epsilon-aminocaproic acid and aprotinin on fibrinolysis and blood loss in patients undergoing primary, isolated coronary artery bypass surgery: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Greilich PE; Jessen ME; Satyanarayana N; Whitten CW; Nuttall GA; Beckham JM; Wall MH; Butterworth JF
    Anesth Analg; 2009 Jul; 109(1):15-24. PubMed ID: 19535691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.